(4 + 2) ipso ‐Annulation of para ‐Quinone Methides with Enone‐Tethered Indoles: Access to Spiro(Pyrroloquinoline‐Cyclohexadienone) Scaffolds
Advanced Synthesis & Catalysis · 13.11.2025 · 367 (21)
DOI: 10.1002/adsc.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 13.09.2025. Verfasst von Km Roshani und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
An unprecedented base‐mediated formal (4 + 2) ipso ‐cyclization of para ‐quinone methides ( p ‐QMs) with enone‐tethered indoles to provide an extensive array of spiro(pyrroloquinolines‐cyclohexadienones) in good to excellent yield and highly diastereoselective manner bearing two stereocenters, and a quaternary spiro center is described. The tetracyclic 1,7‐fuzed indoles are effectively produced from easily accessible starting materials under mild conditions. The settled protocols feature operational simplicity, high atom economy, gram‐scale synthesis, and postsynthetic modifications. The reaction mechanism is proposed with the support of experimental studies.
Zitieren
APA
Roshani, K., Raza, M. S., & Peddinti, R. K. (2025). (4 + 2) ipso ‐Annulation of para ‐Quinone Methides with Enone‐Tethered Indoles: Access to Spiro(Pyrroloquinoline‐Cyclohexadienone) Scaffolds. Advanced Synthesis & Catalysis, 367(21). https://doi.org/10.1002/adsc.70105
Vancouver
Roshani K, Raza MS, Peddinti RK. (4 + 2) ipso ‐Annulation of para ‐Quinone Methides with Enone‐Tethered Indoles: Access to Spiro(Pyrroloquinoline‐Cyclohexadienone) Scaffolds. Advanced Synthesis & Catalysis. 2025;367(21). doi:10.1002/adsc.70105
BibTeX
@article{Roshani2025,
author = {Roshani, Km and Raza, Mohammad Saim and Peddinti, Rama Krishna},
title = {(4 + 2) ipso ‐Annulation of para ‐Quinone Methides with Enone‐Tethered Indoles: Access to Spiro(Pyrroloquinoline‐Cyclohexadienone) Scaffolds},
journal = {Advanced Synthesis & Catalysis},
year = {2025},
volume = {367},
number = {21},
doi = {10.1002/adsc.70105}
}
EUVIMED